top of page
BioTime SARS-CoV-2 IgM/IgG Rapid Qualitative Test
Our BioTime SARS-CoV-2 IgM/IgG Rapid Qualitative Test is a Highly Accurate with good Sensitivity & Specificity.
Product Features:
FDA EUA, CE Declaration of Conformity, MHRA, Register in Russia, Ecuador, Peru, Ukraine, Chile, Brazil, Philippines, Honduras, etc.
-
Test Results within 10 minutes
-
Whole blood, plasma and serum available
-
Low risk of infection for operator
-
No equipment needed
-
Control set available
Clinical Performance:
Test with whole blood
Sensitivity
Specificity
IgM
68.1% (196/288)
100% (234/234)
IgG
IgG/IgM
96.2% (277/288)
98.7% (231/234)
96.2% (277/288)
98.7% (231/234)
Test with plasma
IgM
IgG
IgG/IgM
67.2% (215/320)
97.0% (457/471)
96.6% (309/320)
97.9% (461/471)
96.6% (309/320)
96.4% (454/471)
Sensitivity
Specificity